Care of patients coinfected with HIV and hepatitis C virus:: 2007 updated recommendations from the HCV-HIV International Panel

被引:255
作者
Soriano, Vincent
Puoti, Massimo
Sulkowski, Mark
Cargnel, Antonietta
Benhamou, Yves
Peters, Marion
Mauss, Stefan
Brau, Norbert
Hatzakis, Angelos
Pol, Stanislas
Rockstroh, Juergen
机构
[1] Hosp Carlos III, Dept Infect Dis, Madrid 28029, Spain
[2] Univ Hosp Brescia, Dept Infect Dis, Brescia, Italy
[3] Johns Hopkins Med Inst, Viral Hepatitis Ctr, Baltimore, MD 21205 USA
[4] Osped L Sacco, Dept Infect Dis, Milan, Italy
[5] Hop La Pitie Salpetriere, Dept Hepatol, Paris, France
[6] Univ Calif San Francisco, Hepatol Unit, San Francisco, CA 94143 USA
[7] Ctr HIV & Hepatogastroenterol, Dusseldorf, Germany
[8] Mt Sinai Sch Med, Div Infect Dis & Liver Dis, New York, NY USA
[9] Univ Athens, Sch Med, GR-11527 Athens, Greece
[10] Necker Cochin Hosp, Liver Unit, Paris, France
[11] Univ Hosp Bonn, Dept Med 1, Bonn, Germany
关键词
HCV; HIV; liver; interferon; ribavirin;
D O I
10.1097/QAD.0b013e3281084e4d
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:1073 / 1089
页数:17
相关论文
共 210 条
[1]  
Aceti A, 2002, J ACQ IMMUN DEF SYND, V29, P41, DOI 10.1097/00042560-200201010-00005
[2]   Epoetin alfa maintains ribavirin dose in HCV-infected patients: A prospective, double-blind, randomized controlled study [J].
Afdhal, NH ;
Dieterich, DT ;
Pockros, PJ ;
Schiff, ER ;
Shiffman, ML ;
Sulkowski, MS ;
Wright, T ;
Younossi, Z ;
Goon, BL ;
Tang, KL ;
Bowers, PJ .
GASTROENTEROLOGY, 2004, 126 (05) :1302-1311
[3]   Towards more individualised management of hepatitis C virus patients with initially or persistently normal alanineaminotransferase levels [J].
Alberti, A .
JOURNAL OF HEPATOLOGY, 2005, 42 (02) :266-274
[4]   Prevalence of liver disease in a population of asymptomatic persons with hepatitis C virus infection [J].
Alberti, A ;
Noventa, F ;
Benvegnù, L ;
Boccato, S ;
Gatta, A .
ANNALS OF INTERNAL MEDICINE, 2002, 137 (12) :961-964
[5]   Short statement of the first European consensus conference on the treatment of chronic hepatitis B and C in HIV co-infected patients [J].
Alberti, A ;
Clumeck, N ;
Collins, S ;
Gerlich, W ;
Lundgren, J ;
Palù, G ;
Reiss, P ;
Thiebaut, R ;
Weiland, O ;
Yazdanpanah, Y ;
Zeuzem, S .
JOURNAL OF HEPATOLOGY, 2005, 42 (05) :615-624
[6]   Hepatitis C virus coinfection increases mortality in HIV-infected patients in the highly active antiretroviral therapy era: Data from the HIV Atlanta VA Cohort Study [J].
Anderson, KB ;
Guest, JL ;
Rimland, D .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (10) :1507-1513
[7]   Treatment of patients with HCV infection with or without liver biopsy [J].
Andriulli, A ;
Persico, M ;
Iacobellis, A ;
Maio, G ;
Di Salvo, D ;
Spadaccini, A ;
Bacca, D ;
Leandro, G ;
Ventrella, F ;
Mangia, A .
JOURNAL OF VIRAL HEPATITIS, 2004, 11 (06) :536-542
[8]   Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients with HIV and hepatitis C virus coinfection [J].
Aranzabal, L ;
Casado, JL ;
Moya, J ;
Quereda, C ;
Diz, S ;
Moreno, A ;
Moreno, L ;
Antela, A ;
Perez-Elías, MJ ;
Dronda, F ;
Marín, A ;
Hernandez-Ranz, F ;
Moreno, A ;
Moreno, S .
CLINICAL INFECTIOUS DISEASES, 2005, 40 (04) :588-593
[9]   Single (B or C), dual (BC or BD) and triple (BCD) viral hepatitis in HIV-infected patients in Madrid, Spain [J].
Arribas, JR ;
González-García, JJ ;
Lorenzo, A ;
Montero, D ;
de Guevara, CL ;
Montes, A ;
Hernández, S ;
Pacheco, R ;
Peña, JM ;
Vázquez, JJ .
AIDS, 2005, 19 (13) :1361-1365
[10]   Early HCV dynamics on Peg-interferon and ribavirin in HIV/HCV co-infection:: indications for the investigation of new treatment approaches [J].
Ballesteros, AL ;
Franco, S ;
Fuster, D ;
Planas, R ;
Martínez, MA ;
Acosta, L ;
Sirera, G ;
Salas, A ;
Tor, J ;
Rey-Joly, C ;
Clotet, B ;
Tural, C .
AIDS, 2004, 18 (01) :59-66